| Date | Time | Source | Headline | Symbol | Company |
| 02/03/2013 | 00:49 | Edgar (US Regulatory) | (25-NSE) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 27/02/2013 | 05:02 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 15/02/2013 | 02:02 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 15/02/2013 | 02:02 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 14/02/2013 | 22:08 | Edgar (US Regulatory) | Statement of Ownership (sc 13g) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 14/02/2013 | 22:08 | Edgar (US Regulatory) | Statement of Ownership (sc 13g) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 13/02/2013 | 00:07 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (defa14a) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 13/02/2013 | 00:03 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 06/02/2013 | 01:01 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 25/01/2013 | 07:51 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 24/01/2013 | 09:26 | Edgar (US Regulatory) | Proxy Statement - Merger or Acquistion (definitive) (defm14a) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 15/01/2013 | 00:06 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 15/01/2013 | 00:06 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 09/01/2013 | 07:33 | Edgar (US Regulatory) | Definitive Materials Filed by Investment Companies. (497) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 09/01/2013 | 07:33 | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 09/01/2013 | 07:33 | Edgar (US Regulatory) | Filing of certain prospectuses and communications in connection with business combination transactions (425) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 09/01/2013 | 05:40 | Zacks | Repligen, Pfizer Collaborate - Analyst Blog | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 08/01/2013 | 02:24 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 08/01/2013 | 02:24 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 05/01/2013 | 05:16 | Zacks | BioMimetic's Pipeline Progresses - Analyst Blog | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 04/01/2013 | 09:10 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 04/01/2013 | 09:10 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 04/01/2013 | 09:08 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (DEFA14A) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 04/01/2013 | 09:08 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (defa14a) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 04/01/2013 | 01:00 | Business Wire | BioMimetic Therapeutics, Inc. Initiates Enrollment in Augment™ Chronic Tendinopathy Clinical Trial | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 03/01/2013 | 19:14 | Zacks | Zacks #1 Rank Additions for Thursday - Tale of the Tape | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 26/12/2012 | 22:03 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (defa14a) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 26/12/2012 | 22:03 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (DEFA14A) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 26/12/2012 | 22:03 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 26/12/2012 | 22:03 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |